Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
20.08. | GSK bags breakthrough status for B7-H3 ADC for lung cancer | ||
20.08. | US govt taps Walgreens for decentralised trials | ||
19.08. | NGOs plead for Gaza ceasefire for polio vaccinations | ||
19.08. | Kamala Harris vows to extend key health reforms to all in US | ||
19.08. | EU starts review of Enhertu in HER2-ultra-low breast cancer | ||
19.08. | EU starts review of Enhertu in HER2-ultralow breast cancer | ||
19.08. | Pfizer and BioNTech's COVID/flu vaccine hits a hurdle | ||
16.08. | Lykos co-founder Doblin to step down after MDMA setback | ||
16.08. | With FDA okay, AZ takes on MSD in early-stage lung cancer | ||
16.08. | As WHO calls mpox emergency, NIH says only drug ineffective | ||
16.08. | Biden, Harris 'just getting started' on IRA drug price cuts | ||
15.08. | IRA negotiated prices revealed as Biden claims $6bn savings | ||
15.08. | AI chatbots struggle to interpret patient descriptions | ||
15.08. | PBC drug choices rise in US with OK for Gilead's seladelpar | ||
15.08. | Incyte builds GvHD presence with Niktimvo approval | ||
15.08. | Theramex's uterine fibroid drug Yselty backed for NHS use | ||
15.08. | AstraZeneca said to be wavering on £450m UK vaccine plant | ||
14.08. | AI medtech specialist Firefly lists on Nasdaq after merger | ||
14.08. | Baxter slims down again, selling kidney division to Carlyle | ||
14.08. | AZ gets landmark approval for Imfinzi/Lynparza combo | ||
14.08. | Africa on high alert as mpox cases rise quickly | ||
14.08. | Otsuka, Click's depression DTx launches in the US | ||
13.08. | Remembering Paul Bannister, dear friend and finance manager | ||
13.08. | Remembering Paul Bannister, our dear friend and finance manager | ||
13.08. | Galderma gets FDA nod for prurigo nodularis therapy |